Premium
SSRI use in pregnancy tied to lower risk of preterm birth
Publication year - 2015
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30090
Subject(s) - medicine , pregnancy , obstetrics , serotonin reuptake inhibitor , medical prescription , cohort , cohort study , psychiatry , antidepressant , anxiety , genetics , pharmacology , biology
A population‐based cohort study conducted in Finland has found that the risk of preterm birth was lower for pregnant women who received a selective serotonin reuptake inhibitor (SSRI) prescription during pregnancy than for women who had a psychiatric diagnosis but no medication exposure during pregnancy. The children of women receiving SSRIs during pregnancy did have a higher risk of neonatal complications. Study results were published online August 4 in the American Journal of Psychiatry .